Development of an In Vitro Assay to Assess Pharmacological Compounds and Reversion of Tumor-Derived Immunosuppression of Dendritic Cells

References

• Alfaro C, Suarez N, Gonzalez A, Solano S, Erro L, Dubrot J, Palazon A, Hervas-Stubbs S, Gurpide A, Lopez-Picazo JM, et al. 2009. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer. 100(7):1111–19.
   PubMed Web of Science ®Google Scholar
• Amodio G, Comi M, Tomasoni D, Gianolini ME, Rizzo R, Lemaoult J, Roncarolo MG, Gregori S. 2015. Hla-g expression levels influence the tolerogenic activity of human DC-10. Haematologica. 100(4):548–57.
   PubMed Web of Science ®Google Scholar
• Amodio G, Gregori S. 2012. Human tolerogenic DC-10: perspectives for clinical applications. Transplant Res. 1:14.
   PubMedGoogle Scholar
• Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol. 18(1):767–811.
   PubMed Web of Science ®Google Scholar
• Belladonna ML, Volpi C, Bianchi R, Vacca C, Orabona C, Pallotta MT, Boon L, Gizzi S, Fioretti MC, Grohmann U, et al. 2008. Cutting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J Immunol (Baltimore Md: 1950). 181(8):5194–98.
   PubMed Web of Science ®Google Scholar
• Bertho N, Drénou B, Laupeze B, Le Berre C, Amiot L, Grosset J-M, Fardel O, Charron D, Mooney N, Fauchet R. 2000. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J Immunol. 164(5):2379–85.
   PubMed Web of Science ®Google Scholar
• Bharadwaj U, Li M, Zhang R, Chen C, Yao Q. 2007. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 67(11):5479–88.
   PubMed Web of Science ®Google Scholar
• Boks MA, Kager-Groenland JR, Haasjes MSP, Zwaginga JJ, van Ham SM, Ten Brinke A. 2012. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction — a comparative study of human clinical-applicable DC. Clin Immunol. 142(3):332–42.
   PubMed Web of Science ®Google Scholar
• Cao W, Lee SH, Lu J. 2005. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J. 385(1):85–93.
   PubMedGoogle Scholar
• Carosella ED, Gregori S, LeMaoult J. 2011. The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood. 118(25):6499–505.
   PubMed Web of Science ®Google Scholar
• Dudek AM, Martin S, Garg AD, Agostinis P. 2013. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. 4:438.
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Dunbar DR, Howie SE, Sethi T, Gregory CD. 2009. Human dendritic cells produce TGF- 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J Immunol. 182(5):2795–807.
   PubMed Web of Science ®Google Scholar
• Eisenbarth SC. 2019. Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol. 19(2):89–103.
   PubMed Web of Science ®Google Scholar
• Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, Hauben E, Roncarolo MG. 2010. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10 – dependent ILT4/HLA-G pathway. Blood. 116(6):935–44.
   PubMed Web of Science ®Google Scholar
• Haniffa MA, Wang X-N, Holtick U, Rae M, Isaacs JD, Dickinson AM, Hilkens CMU, Collin MP. 2007. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol. 179(3):1595–604.
   PubMed Web of Science ®Google Scholar
• Jensen SS, Gad M. 2010. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm. 7(37):1–12.
   Google Scholar
• Khosravi-Maharlooei M, Pakyari M, Jalili RB, Salimi-Elizei S, Lai JCY, Poormasjedi-Meibod M, Kilani RT, Dutz J, Ghahary A. 2016. Tolerogenic effect of mouse fibroblasts on dendritic cells. Immunology. 148(1):22–33.
   PubMed Web of Science ®Google Scholar
• Kim H-J, Cantor H. 2014. CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful. Cancer Immunol Res. 2(2):91–98.
   PubMed Web of Science ®Google Scholar
• Lechner MG, Liebertz DJ, Epstein AL. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 185(4):2273–84.
   PubMed Web of Science ®Google Scholar
• Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, Woo T, Epstein AL. 2011. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J Transl Med. 9(1):90.
   PubMedGoogle Scholar
• Ledderose C, Heyn J, Limbeck E, Kreth S. 2011. Selection of reliable reference genes for quantitative real-time PCR in human T cells and neutrophils. BMC Res Notes. 4(1):427.
   PubMedGoogle Scholar
• Lutz MB. 2012. Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front Immunol. 3:123.
   PubMed Web of Science ®Google Scholar
• Lutz MB, Schuler G. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23(9):445–49.
   PubMed Web of Science ®Google Scholar
• Matasić R, Dietz AB, Vuk-Pavlović S. 1999. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol. 66(6):909–14.
   PubMed Web of Science ®Google Scholar
• Michielsen AJ, Hogan AE, Marry J, Tosetto M, Cox F, Hyland JM, Sheahan KD, O’Donoghue DP, Mulcahy HE, Ryan EJ, et al. 2011. Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer. PLoS One. 6(11):e27944.
   PubMed Web of Science ®Google Scholar
• Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P. 1999. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol. 11(5):803–11.
   PubMed Web of Science ®Google Scholar
• Naranjo-Gómez M, Raïch-Regué D, Oñate C, Grau-López L, Ramo-Tello C, Pujol-Borrell R, Martínez-Cáceres E, Borràs FE. 2011. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med. 9(1):89.
   PubMedGoogle Scholar
• Okada SL, Simmons RM, Franke-Welch S, Nguyen TH, Korman AJ, Dillon SR, Gilbertson DG. 2018. Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype. Cell Immunol. 323:49–58.
   PubMed Web of Science ®Google Scholar
• Pitt JM, Vétizou M, Daillère R, Roberti MP, Yamazaki T, Routy B, Lepage P, Boneca IG, Chamaillard M, Kroemer G, et al. 2016. Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity. 44(6):1255–69.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2020. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing. https://ind01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.r-project.org%2F&data=02%7C01%7Csathyan.dhanasekaran%40integra.co.in%7C3c218fcd714e40f48c2608d8136cc36e%7C70e2bc386b4b43a19821a49c0a744f3d%7C0%7C0%7C637280705159982066&sdata=tXd0zUQhY%2FmBUV9KNKXzvzkve%2F43Ri5MbsyCBbZ9ee4%3D&reserved=0
   Google Scholar
• Seliger B, Massa C. 2013. The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape. Front Immunol. 4:419.
   PubMed Web of Science ®Google Scholar
• Silvano A. 2014. Dendritic cells: phenotypic and functional heterogeneity. Ital J Anat Embryol. 119(3):304–30.
   PubMedGoogle Scholar
• Wang L, Fan J, Ye W, Han J, Zhang Y, Zhao L, Duan J, Yin D, Yi Y. 2019. The expression of ILT4 in myeloid dendritic cells in patients with hepatocellular carcinoma. Immunol Invest. 48(7):704–18.
   PubMed Web of Science ®Google Scholar
• Wickham H. 2016. ggplot2: elegant graphics for data analysis. New York (NY): Springer-Verlag. https://ind01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fggplot2.tidyverse.org%2F&data=02%7C01%7Csathyan.dhanasekaran%40integra.co.in%7C3c218fcd714e40f48c2608d8136cc36e%7C70e2bc386b4b43a19821a49c0a744f3d%7C0%7C0%7C637280705159982066&sdata=gDrSebV7dpdqxMj33ux6moqaEkcNd%2BJQqtmPqDEENgc%3D&reserved=0
   Google Scholar
• Zhou LJ, Tedder TF. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol (Baltimore Md: 1950). 154(8):3821–35.
   PubMed Web of Science ®Google Scholar